ELOCTATE न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eloctate

pharmacy retailing (nz) ltd t/a healthcare logistics - efmoroctocog alfa 250 [iu];   - powder for infusion - 250 iu - active: efmoroctocog alfa 250 [iu]   excipient: calcium chloride dihydrate histidine polysorbate 20 sodium chloride sucrose water for injection - eloctate is a long-acting antihaemophilic factor (recombinant) indicated in adults and children with haemophilia a (congenital factor viii deficiency) for: · control and prevention of bleeding episodes · routine prophylaxis to prevent or reduce the frequency of bleeding episodes · perioperative management (surgical prophylaxis). eloctate does not contain von willebrand factor, and therefore is not indicated in patients with von willebrand's disease.

Bactall 250mg tablet 250 mg जॉर्डन - अंग्रेज़ी - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

bactall 250mg tablet 250 mg

الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - ciprofloxacin 250 mg - 250 mg

EVOMAX 250mg 250 mg जॉर्डन - अंग्रेज़ी - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

evomax 250mg 250 mg

الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - levofloxacin 250 mg - 250 mg

EVOMAX 250mg 250 mg जॉर्डन - अंग्रेज़ी - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

evomax 250mg 250 mg

الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - levofloxacin 250 mg - 250 mg

Levetiracetam (Pharmacare) न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

levetiracetam (pharmacare)

psm healthcare ltd trading as api consumer brands - levetiracetam 250mg - film coated tablet - 250 mg - active: levetiracetam 250mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry blue 85f20694 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

Zarontin न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

zarontin

clinect nz pty limited - ethosuximide 250mg - soft gelatin capsule - 250 mg - active: ethosuximide 250mg excipient: erythrosine gelatin glycerol macrogol 400 opacode white nsp-78-18022 quinoline yellow sorbitol - zarontin is indicated for the control of petit mal epilepsy

Delaro न्यूज़ीलैंड - अंग्रेज़ी - Ministry for Primary Industries

delaro

bayer new zealand limited - prothioconazole; trifloxystrobin - emulsifiable concentrate - prothioconazole 175 g/litre; trifloxystrobin 150 g/litre - fungicide - fungicide

Naproxen AB 250 mg tabl. बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

naproxen ab 250 mg tabl.

aurobindo sa-nv - naproxen 250 mg - tablet - 250 mg - naproxen 250 mg - naproxen

Klacid Tab 250 250 mg जॉर्डन - अंग्रेज़ी - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

klacid tab 250 250 mg

مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 250 mg - 250 mg

Penciclovir Novartis 250 न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

penciclovir novartis 250

novartis new zealand ltd - penciclovir sodium 13.63 mg/ml equivalent to 12.5 mg/ml penciclovir (250 mg/vial);  ;   - powder for infusion - 250 mg - active: penciclovir sodium 13.63 mg/ml equivalent to 12.5 mg/ml penciclovir (250 mg/vial)